Yakubu Momoh A, Leffler Charles W
Laboratory for Research in Neonatal Physiology, Vascular Biology Program, Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Am J Physiol Cell Physiol. 2002 Dec;283(6):C1687-95. doi: 10.1152/ajpcell.00071.2002. Epub 2002 Aug 22.
We investigated the role of intracellular calcium concentration ([Ca2+]i) in endothelin-1 (ET-1) production, the effects of potential vasospastic agents on [Ca2+]i, and the presence of L-type voltage-dependent Ca2+ channels in cerebral microvascular endothelial cells. Primary cultures of endothelial cells isolated from piglet cerebral microvessels were used. Confluent cells were exposed to either the thromboxane receptor agonist U-46619 (1 microM), 5-hydroxytryptamine (5-HT; 0.1 mM), or lysophosphatidic acid (LPA; 1 microM) alone or after pretreatment with the Ca2+-chelating agent EDTA (100 mM), the L-type Ca2+ channel blocker verapamil (10 microM), or the antagonist of receptor-operated Ca2+ channel SKF-96365 HCl (10 microM) for 15 min. ET-1 production increased from 1.2 (control) to 8.2 (U-46619), 4.9 (5-HT), or 3.9 (LPA) fmol/microg protein, respectively. Such elevated ET-1 biosynthesis was attenuated by verapamil, EDTA, or SKF-96365 HCl. To investigate the presence of L-type voltage-dependent Ca2+ channels in endothelial cells, the [Ca2+]i signal was determined fluorometrically by using fura 2-AM. Superfusion of confluent endothelial cells with U-46619, 5-HT, or LPA significantly increased [Ca2+]i. Pretreatment of endothelial cells with high K+ (60 mM) or nifedipine (4 microM) diminished increases in [Ca2+]i induced by the vasoactive agents. These results indicate that 1) elevated [Ca2+]i signals are involved in ET-1 biosynthesis induced by specific spasmogenic agents, 2) the increases in [Ca2+]i induced by the vasoactive agents tested involve receptor as well as L-type voltage-dependent Ca2+ channels, and 3) primary cultures of cerebral microvascular endothelial cells express L-type voltage-dependent Ca2+ channels.
我们研究了细胞内钙浓度([Ca2+]i)在内皮素-1(ET-1)产生中的作用、潜在血管痉挛剂对[Ca2+]i的影响以及脑微血管内皮细胞中L型电压依赖性Ca2+通道的存在情况。使用从仔猪脑微血管分离的内皮细胞进行原代培养。汇合的细胞单独或在预先用Ca2+螯合剂乙二胺四乙酸(EDTA,100 mM)、L型Ca2+通道阻滞剂维拉帕米(10 microM)或受体操纵性Ca2+通道拮抗剂盐酸SKF-96365(10 microM)预处理15分钟后,暴露于血栓素受体激动剂U-46619(1 microM)、5-羟色胺(5-HT,0.1 mM)或溶血磷脂酸(LPA,1 microM)。ET-1的产生分别从1.2(对照)增加到8.2(U-46619)、4.9(5-HT)或3.9(LPA)fmol/微克蛋白。维拉帕米、EDTA或盐酸SKF-96365可减弱这种ET-1生物合成的升高。为了研究内皮细胞中L型电压依赖性Ca2+通道的存在情况,使用fura 2-AM通过荧光法测定[Ca2+]i信号。用U-46619、5-HT或LPA对汇合的内皮细胞进行灌流可显著增加[Ca2+]i。用高钾(60 mM)或硝苯地平(4 microM)对内皮细胞进行预处理可减少血管活性药物诱导的[Ca2+]i升高。这些结果表明:1)升高的[Ca2+]i信号参与特定致痉挛剂诱导的ET-1生物合成;2)所测试的血管活性药物诱导的[Ca2+]i升高涉及受体以及L型电压依赖性Ca2+通道;3)脑微血管内皮细胞原代培养物表达L型电压依赖性Ca2+通道。